Isothiocyanate

Isothiocyanate

SCHEMBL6153714

N=C=S.O=[N+]([O-])c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSPB1 P04792 1/20 0.56
ALDH1A1 P00352 2/20 0.55
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 4/20 0.54
KMT2A Q03164 4/20 0.54
LMNA P02545 3/20 0.54
MAPT P10636 2/20 0.54
MAPK1 P28482 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
SRD5A2 P31213 1/20 0.51
FFAR1 O14842 1/20 0.50
NR3C1 P04150 1/20 0.49
RAB9A P51151 2/20 0.49
NPC1 O15118 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MYOC Q99972 1/20 0.49
MCL1 Q07820 1/20 0.48
DRD2 P14416 1/20 0.48
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL457863 0.89 HSPB1 (0.68) HSPB1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL6894771 0.84 ALDH1A1 (0.50) HSPB1ALDH1A1KDM4EMEN1KMT2A
Diphenylether SCHEMBL28998326 0.83 ALDH1A1 (0.73) HSPB1ALDH1A1KDM4EMEN1KMT2A
Nitrobenzene SCHEMBL6153617 0.83 ALDH1A1 (0.73) ALDH1A1MEN1KMT2ALMNAMAPT
4,4'-Oxybis(Nitrobenzene) SCHEMBL134332 0.81 HSPB1 (0.79) HSPB1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL11689190 0.81 HSPB1 (0.79) HSPB1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL9183872 0.81 HSPB1 (0.79) HSPB1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL2011179 0.81 HSPB1 (0.79) HSPB1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL1284365 0.80 HSPB1 (0.61) HSPB1ALDH1A1KDM4EMEN1KMT2A
4,4'-Oxybis(Nitrobenzene) SCHEMBL8934595 0.79 HSPB1 (0.76) HSPB1ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP HSPB1 768/4885ALDH1A1 961/4885KDM4E 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.